- জেনেরিক নাম
- Pregabalin
- শক্তি
- 165 mg
- ডোজ ফর্ম
- Cr Tablet
- প্রস্তুতকারক
- The ACME Laboratories Ltd.
Neugalin XR 165 Cr Tablet
Neugalin XR 165 Cr Tablet সম্পর্কে
বাংলাদেশে Neugalin XR 165 Cr Tablet Cr Tablet হিসেবে পাওয়া যায়; এতে Pregabalin আছে (১৬৫ mg)। Neugalin XR 165-এর সাথে Pregabalin-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। Neugalin XR 165 প্রস্তুত করেছে The ACME Laboratories Ltd। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Pregabalin-এর ১০৫টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম GAPA-P 150 mg Capsule-এর, প্রতি ইউনিট ৳ ১।
Neugalin XR 165 Cr Tablet কী?
Neugalin XR 165 is a cr tablet from The ACME Laboratories Ltd., with the generic name Pregabalin. It works in the nervous system, though its exact way of working is not fully understood. It is used for nerve pain from diabetes, after shingles, or spinal cord injury, and for fibromyalgia. The dose and course are decided by your doctor.
Neugalin XR 165-এর ব্যবহার
Neugalin XR 165 165 mg cr tablet is used for nerve pain caused by diabetic peripheral neuropathy, nerve pain following shingles, fibromyalgia and nerve pain related to spinal cord injury. In epilepsy, it is an add-on treatment for partial-onset seizures. The doctor will decide if it is suitable for your condition.
Neugalin XR 165 কীভাবে ব্যবহার করবেন
You can take it with or without food, but try to take it at the same time each day. Swallow the cr tablet with water. Neugalin XR 165 is taken by mouth. Keep the cr tablets in a dry place away from light and heat, and out of the reach of children. The dose and duration are set by your doctor based on your condition. The doctor decides the dose and how long you take it.
Neugalin XR 165-এর পার্শ্বপ্রতিক্রিয়া
Common side effects include dizziness, drowsiness, dry mouth, swelling, blurred vision, weight gain, and difficulty concentrating. Some people may have serious reactions such as swelling of the throat, head and neck, allergic reactions, or breathing problems, especially with other medicines that affect the brain. Call your doctor right away if you notice swelling of the face, throat, or tongue, trouble breathing, a rash, or hives. Contact your doctor if side effects bother you or do not settle. Tell your doctor if these bother you or do not settle.
সতর্কতা ও নিরাপত্তা
Do not take Neugalin XR 165se if you are allergic to Pregabalin or any ingredient in it. Swelling of the throat or face needs emergency care. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment because of a potential risk of tumour growth. Do not stop the medicine suddenly without talking to your doctor.
সাধারণ প্রশ্ন
Why is Neugalin XR 165 prescribed?
Neugalin XR 165 165 mg cr tablet is used for nerve pain caused by diabetic peripheral neuropathy, nerve pain following shingles, fibromyalgia and nerve pain related to spinal cord injury. In epilepsy, it is an add-on treatment for partial-onset seizures.
How is Neugalin XR 165 used?
You can take it with or without food, but try to take it at the same time each day. Swallow the cr tablet with water.
What should I watch for while using Neugalin XR 165?
Common side effects include dizziness, drowsiness, dry mouth, swelling, blurred vision, weight gain, and difficulty concentrating. Some people may have serious reactions such as swelling of the throat, head and neck, allergic reactions, or breathing problems, especially with other medicines that affect the brain.
Who should be careful with Neugalin XR 165?
Do not take Neugalin XR 165se if you are allergic to Pregabalin or any ingredient in it. Swelling of the throat or face needs emergency care.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregabalin is indicated for:- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury ... Read more
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).
Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.
Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).
Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.
Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.
Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
- 75 mg/daily: 82.5 mg/day
- 150 mg/daily: 165 mg/day
- 225 mg/daily: 247.5 mg/day
- 300 mg/daily: 330 mg/day
- 450 mg/daily: 495 mg/day
- 600 mg/daily: 660 mg/day
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.বিকল্প ব্র্যান্ড: Pregabalin
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।